PRINCETON, NJ and REHOVOT, ISRAEL — — 04/04/14 — Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, today announced that the Company received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering the method of use of a core element of Rosetta … (more)
